MBX: the balance sheet

MyFinsight

MBX Biosciences, Inc. (MBX)

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	45,214	75,289	223,125	39,781
Marketable securities	394,763	298,416	168,548	185,125
Prepaid expenses and other current assets	8,559	7,834	5,829	4,284
Total current assets	448,536	381,539	397,502	229,190
Total property and equipment	3,867	3,405	2,614	-
Less accumulated depreciation	734	670	610	-
Property and equipment, net	3,133	2,735	2,004	1,730
Right-of-use assets	453	487	520	551
Other assets	579	383	50	50
Total assets	452,701	385,144	400,076	231,522

Accounts payable	6,974	2,977	3,768	5,764
Accrued expenses	7,415	12,346	8,140	5,854
Operating lease liability, current	178	172	154	138
Total current liabilities	14,567	15,495	12,062	11,756
Share repurchase liability	1	2	7	15
Operating lease liability, net of current	377	424	469	512
Total liabilities	14,945	15,921	12,538	12,283
Common stock, 0.0001 par value, 500,000,000 shares authorized and 47,570,464 issued and outstanding as of march 31, 2026 and 500,000,000 shares authorized and 44,927,953 issued and outstanding as of december 31, 2025	6	6	6	5
Additional paid-in-capital	686,349	593,407	589,792	400,019
Accumulated deficit	-247,993	-224,476	-202,414	-180,796
Accumulated other comprehensive (loss) income	-606	286	154	11
Total stockholders' equity	437,756	369,223	387,538	219,239
Total liabilities and stockholders' equity	452,701	385,144	400,076	231,522

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.